Analogic to Launch Breakthrough Checkpoint Security Screening System for European Aviation Market at Passenger Terminal Expo 2017 in Amsterdam
8.3.2017 17:15 | NASDAQ OMX
PEABODY, Mass., 2017-03-08 17:15 CET (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, today announced that it will launch its ConneCT™ Checkpoint CT (computed tomography) screening system for the European market at the Passenger Terminal Expo in Amsterdam, March 14–16. Utilizing Analogic’s advanced CT technology alongside state-of-the-art threat detection software, the ConneCT incorporates the latest in security and medical innovations to lower airport screening costs, increase passenger throughput and elevate the level of security for the traveling public.
Analogic’s ConneCT is the culmination of 25 years of leadership in advanced CT security screening solutions. Analogic CT technology has been deployed at over 1,200 airports worldwide for checked baggage. The ConneCT checkpoint security system features a new modular imaging system based on advanced medical imaging technology and an interoperable network architecture designed to maximize reliability and achieve the lowest total cost of ownership. Its threat detection software is engineered to allow passengers to keep liquids and electronics in their carry-on baggage, increase staff productivity and reduce false alarms.
“The launch of ConneCT is not only about Analogic’s leadership in CT technology – it also reflects a new direct partnership with technology decision-makers that gives airports more flexibility and lowers costs,” said Jim Ryan, senior vice president of security systems. “Our customers want direct access to the latest in screening technologies and the freedom to make ‘best-of-breed’ choices for complementary checkpoint equipment and software, as well as on-site service support. Analogic will enable dynamic and tailored solutions that evolve with airport needs over the lifecycle of the product.”
“European airports have been early adopters of new technology, recognizing the opportunity to do three key things: improve detection capabilities to keep the traveling public safe, transform the airport experience for the traveling public and get passengers through security quickly so they can enjoy airport shopping and dining venues,” said Mark Laustra, vice president global business development and government relations. “We are pleased to launch ConneCT, our next-generation CT checkpoint scanner.”
Analogic developed CT technology for medical use, adapting the technology for detection and security of checked baggage. The ConneCT has been engineered and designed specifically for airport checkpoints, representing a new industry standard for imaging, with 100x more data available in each image than the previous standard. This allows screeners to manipulate a 3D image to view bags from all angles, revealing items that might otherwise be hidden.
In February of 2016, Neil Thompson, operations director of London Luton Airport, commented on Analogic’s UK trial of COBRA, Analogic’s first-generation checkpoint CT. "Through the trials with Analogic, we have been able to demonstrate ways to significantly improve security checks. Analogic 3D CT technology has shown the promise of providing a great passenger experience whilst improving security."
Analogic will feature the ConneCT scanner at its booth (RAI Amsterdam, Hall 8, Booth #10050) during the Passenger Terminal Expo 2017 next week. On March 16, at 12:55 local time, Mark Laustra will deliver a presentation on the future of aviation security technology and regulation.
The ConneCT screening system has achieved critical milestones on its way toward Transportation Security Administration (TSA) certification in the US and is slated to enter the ECAC certification protocol in the spring of this year. Analogic remains committed to working closely with various international certification agencies and airports this year to bring the ConneCT system to the global market.
About Analogic – Celebrating 50 Years of innovation
Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology solutions to advance the practice of medicine and save lives. We are recognized around the world for advanced imaging and real-time guidance technologies used for disease diagnosis and treatment as well as for automated threat detection. Our market-leading ultrasound systems, led by our flagship BK Ultrasound brand, used in procedure-driven markets such as urology, surgery, and point-of-care, are sold to clinical practitioners around the world. Our advanced imaging technologies are also used in computed tomography (CT), magnetic resonance imaging (MRI) and digital mammography systems, as well as automated threat detection systems for aviation security. Analogic is headquartered just north of Boston, Massachusetts. For more information, visit www.analogic.com.
For further information, please contact:
Director of Investor Relations
Coltrin & Associates, Inc.
Om NASDAQ OMX
NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra NASDAQ OMX
Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra NASDAQ OMX
ZIM Adds MatchBack Systems Analytics Services in Italy21.8.2017 22:00 | Pressemelding
Innovative approach to gain efficiencies through fewer empty container moves adds significant value for ZIM's customers GREEN BAY, Wis. and ROTTERDAM, The Netherlands, Aug. 21, 2017 (GLOBE NEWSWIRE) -- MatchBack Systems, Inc. ( www.matchbacksystems.com ), the leading software as a service (SaaS) solution to plan, optimize and automate matchbacks, announced that ZIM Integrated Shipping Ltd. joined the company's customer base on May 1, 2017 to optimize their inland operation in Italy. The account will be serviced through the European office in Rotterdam and corporate headquarters in North America. The system will be deployed for a 2 months pilot after which the parties will evaluate the scope for a broader cooperation. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1cb9a632-22a4-4ff5-a3d5-d8b3964e5113 Gil Lehmann, Head of Global Land Tra
Promethean Opens New Global Headquarters in Seattle18.8.2017 18:38 | Pressemelding
Seattle, Wash., Aug. 18, 2017 (GLOBE NEWSWIRE) -- PrometheanTM, a global education technology company, announced today the opening of its new global headquarters in Seattle, Wash. Promethean's office in Atlanta, Ga. will continue to serve as the hub for the Americas markets, and the Blackburn, U.K. office will continue to carry on as the hub for the EMEA markets and parts of Asia. Promethean is one of the leading brands in the international education technology market with more than 20 years of experience in the K-12 classroom. Its solutions are in more than 50,000 schools and institutions in 154 countries. "As traditional pedagogy continues to move towards immersive learning, it's important for Promethean to lead innovation in education with the latest technology," said Vin Riera, CEO of Promethean. "Seattle is a global technology hub, and establishing Promethean's global headquarters there increases opportunities for new business models, concepts
Hminers Disrupts the Cryptocurrency Market with Powerful, Multi-Algorithm Mining Rigs18.8.2017 11:00 | Pressemelding
Hminers continues to hit the headlines in the rapidly expanding global market for cryptocurrency. The Miami-based company has recently introduced three extremely powerful, multi-algorithm mining rigs that have been designed to provide maximum hash rate with minimum power consumption. MIAMI, Aug. 18, 2017 (GLOBE NEWSWIRE) -- In their relentless efforts to deliver state-of-the-art products related to cryptocurrency, Hminers has recently launched three brilliantly designed bitcoin mining rigs. The unique features and capabilities of the company's new H2U Miner, H4U Miner, and Rack Equipped with 5 x H4U have already grabbed the attention of the cryptocurrency enthusiasts and experts around the world. An organization with a rich tradition, Hminers (www.hminers.com) is recognized in the industry as the creator of the first ever 10 nm ASIC Chip in the world. Cryptocurrency mining is the process of generating new cryptocurrency that requires a pot
Nasdaq Welcomes I-AM Capital Acquisition Company (Nasdaq: IAMXU) to The Nasdaq Stock Market17.8.2017 18:50 | Pressemelding
NEW YORK, Aug. 17, 2017 (GLOBE NEWSWIRE) -- I-AM Capital Acquisition Company (Nasdaq:IAMXU), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, celebrated its initial public offering (IPO) on The Nasdaq Stock Market. I-AM Capital's founders, Chief Executive Officer F. Jacob Cherian and Chief Financial Officer Suhel Kanuga, have been focused on investing into India over the last decade, with the distinction of completing the first listed-SPAC investment in India. "Through our keen focus and unique accomplishments in India over the last decade, we have seen our investment thesis bear fruit: India's prominence and rise on the world stage, its distinction as being one of the fastest growing major economies of the world, and its strong vibrant consumer demographics. We believe these factors are aligning well now,
Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency17.8.2017 14:30 | Pressemelding
WATERTOWN, Mass., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- resistant (MDR) infections, today announced that the Marketing Authorization Application (MAA) for IV eravacycline for the treatment of complicated intra-abdominal infections (cIAI) has been submitted and was validated by the European Medicines Agency (EMA). Eravacycline is a novel, fully-synthetic fluorocycline antibiotic being developed for the treatment of serious infections, including those caused by multidrug-resistant (MDR) pathogens. The MAA filing is based on data from the phase 3 IGNITE1 clinical trial in which eravacycline was well tolerated and demonstrated statistical non-inferiority to ertapenem using the primary endpoint of clinical response at the test-of-cure (TOC) visit. "The MAA filing represents a significant milestone for Tetraphase as it is our
RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules17.8.2017 13:00 | Pressemelding
RedHill was granted the exclusive rights to promote Esomeprazole Strontium Delayed-Release (DR) Capsules to gastroenterologists in certain U.S. territories Esomeprazole Strontium DR Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI), indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal (GI) conditions RedHill expects to initiate the U.S. promotion of Esomeprazole Strontium DR Capsules 49.3 mg in the coming weeks Esomeprazole Strontium DR Capsules 49.3 mg will be the third commercial GI product to be promoted by RedHill in the U.S. RedHill's GI-focused sales force currently promotes two GI s
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom